Boosting maternal and neonatal anti–SARS-CoV-2 humoral immunity using a third mRNA vaccine dose

BACKGROUND. To minimize COVID-19 pandemic burden and spread, 3-dose vaccination campaigns commenced worldwide. Since patients who are pregnant are at increased risk for severe disease, they were recently included in that policy, despite the lack of available evidence regarding the impact of a third...

Descripción completa

Detalles Bibliográficos
Autores principales: Cahen-Peretz, Adva, Tsaitlin-Mor, Lilah, Allouche Kam, Hadas, Frenkel, Racheli, Kabessa, Maor, Cohen, Sarah M., Lipschuetz, Michal, Oiknine-Djian, Esther, Lianski, Sapir, Goldman-Wohl, Debra, Walfisch, Asnat, Kovo, Michal, Neeman, Michal, Wolf, Dana G., Yagel, Simcha, Beharier, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870074/
https://www.ncbi.nlm.nih.gov/pubmed/36625348
http://dx.doi.org/10.1172/jci.insight.158646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870074/
https://www.ncbi.nlm.nih.gov/pubmed/36625348
http://dx.doi.org/10.1172/jci.insight.158646

Ejemplares similares